Source Code Restrictions. Without limiting Section 4.6, each Party, as a Licensee, acknowledges and agrees that the source code of the Licensed Software licensed to such Party as Licensee is subject to the following restriction: except as expressly licensed herein, any use or distribution of such Licensed Software that requires the source code of the Licensed Software to be made available to anyone but the Licensee is expressly prohibited. Such prohibited use includes, but is not limited to, the incorporation of such source code of the Licensed Software into Software licensed under an Open Source License.
Source Code Restrictions. Licensee agrees not to decompile, reverse engineer, disassemble or otherwise attempt to determine source code for the executable code of the Licensed Software Products or to create any Derivative Works based upon the Licensed Products or Documentation, and agrees not to permit or authorize anyone else to do so.
Source Code Restrictions. NMS agrees not to copy, modify, translate, decompile, reverse engineer, disassemble, or otherwise determine or attempt to determine source code from the System, the Healtheon Service and the Intellectual Property pertaining thereto or to create any derivative works based upon the System, the Healtheon Service and/or the Intellectual Property pertaining thereto, and agrees not to permit or authorize anyone else to do so. Notwithstanding the foregoing, Healtheon acknowledges and agrees that this in no way prohibits NMS from independently developing a system, software, application or tool that is similar in feature and functionality to the Healtheon Service without using any of Healtheon's Confidential Information or Intellectual Property. Healtheon acknowledges that NMS asserts that it began a development project that may have included similar features and functionality to the Healtheon Service, and that such project has been suspended. NMS agrees to provide Healtheon with written notice at least thirty (30) days prior to NMS (i) committing resources to develop a Web-based benefits enrollment application or service with a project plan and deliverables; (ii) making a written or oral commitment to an existing or prospective customer that it is developing and/or will provide a non-Healtheon Web-based benefits enrollment application or service; or (iii) communicating in its sales and marketing program or materials that NMS is developing or will provide a non-Healtheon Web-based benefits enrollment application or service. Healtheon has the right to terminate this Agreement immediately upon receipt of such notice or the discovery of any of the foregoing events. Healtheon acknowledges that NMS, on a regular basis, enhances its capabilities to provide employer/broker self-service capabilities to its existing benefits administration systems and that these types of enhancements are not subject to this Section.
Source Code Restrictions. Company agrees not to copy, modify, translate, decompile, reverse engineer, disassemble, or otherwise determine or attempt to determine source code from the System, the Service and the Intellectual Property pertaining thereto or to create any derivative works based upon the System, the Service and/or the Intellectual Property pertaining thereto, and agrees not to permit anyone under Company's control or to authorize anyone else to do so.
Source Code Restrictions. You will not (and will not authorize or knowingly permit any third party to): (i) disclose all or any portion of the Source Code for the SDK or related Documentation to anyone other than your employees on a need-to-know basis solely for purposes authorized under this Agreement, provided such employees are expressly bound by the nondisclosure obligations equally as protective as those in this Agreement; (ii) reproduce all or any portion of the Source Code for the SDK, in any form or medium, except as necessary for exercising your rights under this Agreement; (iii) allow hard copy printouts of any portion of the Source Code for the SDK to exist except within secured locations; (iv) allow soft copy versions of any portion of the Source Code for the SDK to reside on computers or networks unless such computers or networks are password protected (with such passwords only being made available to such employees); or (v) use any portion of the Source Code for the SDK for any purpose not specifically authorized in this Agreement. You will advise all employees with access to any portion of the Source Code for the SDK of their responsibilities under this Agreement and their respective individual confidentiality agreement both at the time such person’s access to the Source Code for the SDK commences, and at the time such access terminates. You will be responsible for any breach of the requirements in this Section by any of your employees.
Source Code Restrictions. CUSTOMER will not (and will not authorize or knowingly permit any third party to):
Source Code Restrictions. Notwithstanding anything in this Agreement to the contrary, Licensee has no right to transfer, distribute, transmit or otherwise provide the Source Code to any third party. All modifications and derivative works of the Source Code and the Licensed Materials made by or for Licensee shall be the sole property of Xilinx, and Licensee shall acquire no greater rights therein than specifically provided for hereunder, provided that Licensee shall have no obligation to provide such modifications or derivative works to Xilinx or any third party. Licensee accepts the Source Code in “as-is” condition, and agrees that any modifications or other uses of the Source Code are made solely at Licensee’s risk. Xilinx accepts no liability whatsoever for any such modifications or other uses. Licensee further acknowledges and agrees that Xilinx does not commercially support the Source Code, and that the normal Xilinx support facilities will not be made available for the Source Code, including without limitation hotline, documentation, upgrades or future releases.
Source Code Restrictions. Intraware agrees that, except and only to the extent that Netscape makes source code for certain Client Products publicly available on certain public license terms, not to copy (except as expressly permitted by Section 2.1.1), modify, translate, decompile, reverse engineer, disassemble, or otherwise determine or attempt to determine source code from the Netscape Products or to create any Derivative Works based upon the Netscape Products or Documentation, and agrees not to permit or authorize anyone else to do so. Intraware 9/29/98ks Netscape 3 CONFIDENTIAL
Source Code Restrictions. Licensee shall not de-compile, reverse engineer, disassemble, or otherwise determine or attempt to derive source code for the i.c.Xxxx Xxxhnology or to market or use directly or indirectly any derivative works based upon the i.c.Xxxx Xxxhnology and agrees not to permit or authorize anyone else to do so, except as granted under the license terms of this Agreement and only with prior written consent by MAX which will not unreasonably be withheld. Such restriction shall not apply to the Developed Technology, any Derivative Works thereof, or to any applications created pursuant thereto , save and except that Licensee shall not de-compile, reverse engineer, disassemble, or otherwise determine or attempt to derive source code for the media processor native software objects.
Source Code Restrictions. Cisco shall not have the right to distribute or sublicense any source code owned by Frontier unless such source code is distributed or sublicensed with or as part of Cisco source code or Cisco hardware. In no event shall a sublicensee of the Frontier source code have the right to sublicense such source code to other parties or to make modifications of such source code that [*]. Cisco shall protect Software source code provided hereunder and/or sublicensed to others to the same extent that it protects its own source code. [*] indicates material that has been omitted and for which confidential treatment has been requested. All such omitted material has been filed with the Securities and Exchange Commission pursuant to Rule 406 promulgated under the Securities Act of 1933, as amended.
